Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Jin Ah Jung
Kohei Kaku
Jae Hyeon Kim
Jung-Ryul Kim
Jae-Wook Ko
Soo-Youn Lee
Wooseong Huh
机构：
[1] Samsung Medical Center,Department of Clinical Pharmacology and Therapeutics
[2] Kawasaki Medical School,Department of Internal Medicine
[3] Sungkyunkwan University School of Medicine,Department of Internal Medicine, Samsung Medical Center
[4] Sungkyunkwan University,Department of Laboratory Medicine and Genetics, Samsung Medical Center
来源：
Advances in Therapy | 2013年 / 30卷
关键词：
Combination; Oral hypoglycemic agents; Mitiglinide; Sitagliptin; Type 2 diabetes, Phase 1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1018 / 1029
页数：11
相关论文
共 50 条
  • [1] Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus
    Jung, Jin Ah
    Kaku, Kohei
    Kim, Jae Hyeon
    Kim, Jung-Ryul
    Ko, Jae-Wook
    Lee, Soo-Youn
    Huh, Wooseong
    ADVANCES IN THERAPY, 2013, 30 (11) : 1018 - 1029
  • [2] Erratum to: Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus
    Jin Ah Jung
    Kohei Kaku
    Jae Hyeon Kim
    Jung-Ryul Kim
    Jae-Wook Ko
    Soo-Youn Lee
    Wooseong Huh
    Advances in Therapy, 2014, 31 : 149 - 149
  • [3] Additive Postprandial Glucose-Lowering Effects of Mitiglinide and Sitagliptin in Patients with Type 2 Diabetes Mellitus (vol 30, pg 1018, 2013)
    Jung, Jin Ah
    Kaku, Kohei
    Kim, Jae Hyeon
    Kim, Jung-Ryul
    Ko, Jae-Wook
    Lee, Soo-Youn
    Huh, Wooseong
    ADVANCES IN THERAPY, 2014, 31 (01) : 149 - 149
  • [4] The Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes
    Kodera, Ryo
    Shikata, Kenichi
    Nakamura, Akihiko
    Okazaki, Satoru
    Nagase, Ryo
    Nakatou, Tatsuaki
    Haisa, Shigeru
    Hida, Kazuyuki
    Miyashita, Katsuhiro
    Makino, Hirofumi
    INTERNAL MEDICINE, 2017, 56 (06) : 605 - 613
  • [5] Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
    Konya, Hiroyuki
    Katsuno, Tomoyuki
    Tsunoda, Taku
    Yano, Yuzo
    Kamitani, Mai
    Miuchi, Masayuki
    Hamaguchi, Tomoya
    Miyagawa, Jun-Ichiro
    Namba, Mitsuyoshi
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 317 - 325
  • [6] Effects of miglitol versus sitagliptin on postprandial glucose and lipoprotein metabolism in patients with type 2 diabetes mellitus
    Okada, Kenta
    Yagyu, Hiroaki
    Kotani, Kazuhiko
    Yamazaki, Hisataka
    Ozaki, Kazufumi
    Takahashi, Manabu
    Nagashima, Shuichi
    Osuga, Jun-ichi
    Ishibashi, Shun
    ENDOCRINE JOURNAL, 2013, 60 (07) : 913 - 922
  • [7] Glucose-lowering effects of sulfasalazine in type 2 diabetes
    Haas, RM
    Li, P
    Chu, JW
    DIABETES CARE, 2005, 28 (09) : 2238 - 2239
  • [8] Haemostasiologic effects of various glucose-lowering medications in type 2 diabetes mellitus.
    Petrik, G. G.
    Pavlishchuk, S. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2010, 9 (02): : 48 - 53
  • [9] Initiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice
    Spoelstra, JA
    Stolk, RP
    Klungel, OH
    Erkens, JA
    Rutten, GEHM
    Leufkens, HGM
    Grobbee, DE
    DIABETIC MEDICINE, 2004, 21 (08) : 896 - 900
  • [10] Factors associated with the glucose-lowering efficacy of sitagliptin in Japanese patients with type 2 diabetes mellitus: Pooled analysis of Japanese clinical trials
    Tajima, Naoko
    Eiki, Jun-ichi
    Okamoto, Taro
    Okuyama, Kotoba
    Kawashima, Masaru
    Engel, Samuel S.
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (03) : 640 - 646
12345